185 related articles for article (PubMed ID: 37172717)
1. Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma.
Fu Y; Liang X; Yang X; Liu J; Huang H; Zhang P; Li S; Zhu D; Zhang Y; Peng F; Chen Y; Chen Z
Mol Cell Proteomics; 2023 Jun; 22(6):100567. PubMed ID: 37172717
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis.
Yang J; Zhou M; Zhao R; Peng S; Luo Z; Li X; Cao L; Tang K; Ma J; Xiong W; Fan S; Schmitt DC; Tan M; Li X; Li G
J Proteomics; 2014 Sep; 109():162-75. PubMed ID: 24998431
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma.
Lin SJ; Chang KP; Hsu CW; Chi LM; Chien KY; Liang Y; Tsai MH; Lin YT; Yu JS
J Proteomics; 2013 Dec; 94():186-201. PubMed ID: 24080422
[TBL] [Abstract][Full Text] [Related]
4. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
[TBL] [Abstract][Full Text] [Related]
5. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.
Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960
[TBL] [Abstract][Full Text] [Related]
7. iTRAQ-Based Quantitative Proteomic Analysis of Nasopharyngeal Carcinoma.
Cai XZ; Zeng WQ; Xiang Y; Liu Y; Zhang HM; Li H; She S; Yang M; Xia K; Peng SF
J Cell Biochem; 2015 Jul; 116(7):1431-41. PubMed ID: 25648846
[TBL] [Abstract][Full Text] [Related]
8. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
Deng YF; Zhou DN; Pan ZY; Yin P
Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
[TBL] [Abstract][Full Text] [Related]
9. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.
Wu P; Zhang H; Qi L; Tang Q; Tang Y; Xie Z; Lv Y; Zhao S; Jiang W
Oncol Rep; 2012 Apr; 27(4):987-94. PubMed ID: 22160175
[TBL] [Abstract][Full Text] [Related]
10. Omics-based identification of biomarkers for nasopharyngeal carcinoma.
Janvilisri T
Dis Markers; 2015; 2015():762128. PubMed ID: 25999660
[TBL] [Abstract][Full Text] [Related]
11. Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma.
Li M; Li C; Li D; Xie Y; Shi J; Li G; Guan Y; Li M; Zhang P; Peng F; Xiao Z; Chen Z
Clin Exp Metastasis; 2012 Dec; 29(8):865-77. PubMed ID: 22706927
[TBL] [Abstract][Full Text] [Related]
12. NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.
Feng S; Yang G; Yang H; Liang Z; Zhang R; Fan Y; Zhang G
Cell Cycle; 2017 May; 16(9):869-878. PubMed ID: 28379054
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal Carcinoma Protein Interaction Mapping Analysis via Proteomic Approaches.
Zamanian Azodi M; Rezaei Tavirani M; Rezaei Tavirani M; Vafaee R; Rostami-Nejad M
Asian Pac J Cancer Prev; 2018 Mar; 19(3):845-851. PubMed ID: 29582644
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma.
Chen C; Wang C; Pang R; Liu H; Yin W; Chen J; Tao L
J Transl Med; 2023 Apr; 21(1):278. PubMed ID: 37098551
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of a nasopharyngeal carcinoma cell line and a nasopharyngeal epithelial cell line.
Huang PY; Zeng TT; Li MQ; Ban X; Zhu YH; Zhang BZ; Mai HQ; Zhang L; Guan XY; Li Y
Tumori; 2015; 101(6):676-83. PubMed ID: 26108243
[TBL] [Abstract][Full Text] [Related]
16. A Review: Proteomics in Nasopharyngeal Carcinoma.
Chen ZT; Liang ZG; Zhu XD
Int J Mol Sci; 2015 Jul; 16(7):15497-530. PubMed ID: 26184160
[TBL] [Abstract][Full Text] [Related]
17. Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis.
Tang CE; Tan T; Li C; Chen ZC; Ruan L; Wang HH; Su T; Zhang PF; Xiao ZQ
Oncol Rep; 2010 Aug; 24(2):495-500. PubMed ID: 20596638
[TBL] [Abstract][Full Text] [Related]
18. Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.
Kontos CK; Fendri A; Khabir A; Mokdad-Gargouri R; Scorilas A
BMC Cancer; 2013 Jun; 13():293. PubMed ID: 23777485
[TBL] [Abstract][Full Text] [Related]
19. Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance.
Liu J; Tang G; Huang H; Li H; Zhang P; Xu L
Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2563-2573. PubMed ID: 30121842
[TBL] [Abstract][Full Text] [Related]
20. PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.
Wang MY; Lin ZR; Cao Y; Zheng LS; Peng LX; Sun R; Meng DF; Xie P; Yang JP; Cao L; Xu L; Huang BJ; Qian CN
Oncotarget; 2016 May; 7(18):26604-16. PubMed ID: 27049917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
